The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Immune infiltration and angiogenesis as markers of outcome in the post-nephrectomy setting: Transcriptomic data from patients receiving placebo on a randomized phase III trial (PROTECT).
 
A. Ari Hakimi
No Relationships to Disclose
 
Martin H Voss
Stock and Other Ownership Interests - CellGenix (I)
Consulting or Advisory Role - Alexion Pharmaceuticals; Calithera Biosciences; Corvus Pharmaceuticals; Eisai; Exelixis; GlaxoSmithKline; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb; Genentech/Roche; Pfizer
Travel, Accommodations, Expenses - AstraZeneca; Eisai; Takeda
 
Fengshen Kuo
No Relationships to Disclose
 
Andrew W. Silagy
No Relationships to Disclose
 
Mahtab Marker
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Albert Reising
Employment - Novartis; Novartis
Stock and Other Ownership Interests - Novartis
 
John Millholland
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Timothy An-thy Chan
Leadership - Illumina
Stock and Other Ownership Interests - AN2H; Gritstone Bio
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Lilly; Merck; Pfizer; Roche
Research Funding - AN2H; AstraZeneca; Bristol-Myers Squibb; Eisai; Illumina; Pfizer
Patents, Royalties, Other Intellectual Property - Intellectual Property Neoantigen discovery and genomic biomarkers for immunotherapy response
 
Paul Russo
No Relationships to Disclose
 
Robert J. Motzer
Consulting or Advisory Role - Eisai; Exelixis; Genentech/Roche; Incyte; Lilly; Merck; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Eisai (Inst); Genentech/Roche (Inst); Novartis (Inst); Pfizer (Inst)